10-May-2024
No headlines found.
Business Wire (Tue, 7-May 2:23 PM ET)
Acadia Healthcare to Participate in BofA Securities Health Care Conference
Business Wire (Tue, 7-May 11:00 AM ET)
Acadia Healthcare Reports First Quarter 2024 Results, Affirms Full Year 2024 Guidance
Business Wire (Wed, 1-May 4:05 PM ET)
Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening
Business Wire (Thu, 11-Apr 2:16 PM ET)
Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer
Business Wire (Thu, 4-Apr 9:00 AM ET)
Acadia Healthcare Announces Date for First Quarter 2024 Earnings Release
Business Wire (Wed, 3-Apr 11:00 AM ET)
Acadia Healthcare Accelerates Access to Care With Uber Health
Business Wire (Tue, 2-Apr 9:00 AM ET)
Globe Newswire (Thu, 28-Mar 1:07 PM ET)
Acadia Healthcare Acquires Three Comprehensive Treatment Centers in North Carolina
Business Wire (Thu, 28-Mar 10:00 AM ET)
Business Wire (Wed, 27-Mar 1:13 PM ET)
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
Acadia Healthcare Company trades on the NASDAQ stock market under the symbol ACHC.
As of May 10, 2024, ACHC stock price climbed to $71.81 with 1,629,436 million shares trading.
ACHC has a beta of 0.94, meaning it tends to be less sensitive to market movements. ACHC has a correlation of 0.16 to the broad based SPY ETF.
ACHC has a market cap of $6.66 billion. This is considered a Mid Cap stock.
Last quarter Acadia Healthcare Company reported $768 million in Revenue and $.84 earnings per share. This fell short of revenue expectation by $-11 million and exceeded earnings estimates by $.03.
In the last 3 years, ACHC stock traded as high as $89.85 and as low as $50.07.
The top ETF exchange traded funds that ACHC belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
ACHC has underperformed the market in the last year with a price return of +2.8% while the SPY ETF gained +27.8%. ACHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.5% and -2.4%, respectively, while the SPY returned +4.2% and +2.5%, respectively.
ACHC support price is $68.91 and resistance is $72.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHC stock will trade within this expected range on the day.